Skip to main content

Table 1 Antiproliferative effect of NVP-AUY922 against a panel of human breast cancer cell lines

From: NVP-AUY922: a small molecule HSP90 inhibitor with potent antitumor activity in preclinical breast cancer models

Cell line

ErbB2/ER status

NVP-AUY922

17-AAG

  

nM

BT-474

ErbB2+/ER+

3.1 ± 1.4

17.4 ± 5.2

BT20

ErbB2-/ER-

4.0 ± 1.4

18.9 ± 4.8

MDA-MB-157

ErbB2-/ER-

126 ± 37

29.5 ± 20.8

MDA-MB-231

ErbB2-/ER-

7.0 ± 1.7

2,057 ± 571

MDA-MB-468

ErbB2-/ER-

6.3 ± 2.6

1,657 ± 390

SkBr3

ErbB2+/ER-

3.3 ± 0.9

11.9 ± 8.0

MCF-7

ErbB2-/ER-

8.8 ± 1.8

69.0 ± 18.3

  1. The concentrations of NVP-AUY922 and tanespimycin (17-AAG) that inhibit cell number by 50% (GI50) were determined. ErbB2 and estrogen receptor (ER) status is indicated.